Talk:Insulin glulisine

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Insulin glulisine.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

WikiProject class rating edit

Latest comment: 13 years ago2 comments2 people in discussion

This article was automatically assessed because at least one WikiProject had rated the article as start, and the rating on other projects was brought up to start class. BetacommandBot 16:28, 10 November 2007 (UTC)Reply

Insulin glulisine has the similar advantages to other insulin analogues over ordinary insulin including: Better control of meal-time glycaemia, lower incidence of postprandial hypoglycaemia & greater reducing in HbA1c (use for assessment of diabetes mellitus treatment) than regular insulin —Preceding unsigned comment added by 41.236.235.48 (talk) 14:34, 6 May 2010 (UTC)Reply

really need an expert? edit

Latest comment: 11 years ago1 comment1 person in discussion

The topic is marked as needing an expert in pharmacology. While this would be ideal, the main issue is that the article is only a stub. A knowledgeable non-expert could improve it greatly. (I could do it but unfortunately I don't have time.) Paleolith (talk) 20:53, 16 September 2012 (UTC)Reply

Add topic